Trigatti B L, Rigotti A, Braun A
Biology Department, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Biochim Biophys Acta. 2000 Dec 15;1529(1-3):276-86. doi: 10.1016/s1388-1981(00)00154-2.
High-density lipoproteins (HDL) play an important role in protection against atherosclerosis by mediating reverse cholesterol transport - the transport of excess cholesterol from peripheral tissues to the liver for disposal. SR-BI is a cell surface receptor for HDL and other lipoproteins (LDL and VLDL) and mediates the selective uptake of lipoprotein cholesterol by cells. Overexpression or genetic ablation of SR-BI in mice revealed that it plays an important role in HDL metabolism and reverse cholesterol transport and protects against atherosclerosis in mouse models of the disease. If it plays a similar role in humans then it may be an attractive target for therapeutic intervention. We will review some of the recent advances in the understanding of SR-BI's physiological role and cellular function in lipoprotein metabolism.
高密度脂蛋白(HDL)通过介导逆向胆固醇转运——将外周组织中多余的胆固醇转运至肝脏进行清除,在预防动脉粥样硬化中发挥重要作用。SR-BI是HDL及其他脂蛋白(低密度脂蛋白和极低密度脂蛋白)的细胞表面受体,介导细胞对脂蛋白胆固醇的选择性摄取。在小鼠中过表达或基因敲除SR-BI表明,它在HDL代谢和逆向胆固醇转运中起重要作用,并在该疾病的小鼠模型中预防动脉粥样硬化。如果它在人类中发挥类似作用,那么它可能是一个有吸引力的治疗干预靶点。我们将综述在理解SR-BI在脂蛋白代谢中的生理作用和细胞功能方面的一些最新进展。